Derm NP/PA Connect

Explore common dermatological nail disorders and innovative surgical techniques presented by Phoebe Rich, MD, at Maui Derm NP+PA Fall 2025.

At Maui Derm NP+PA Fall 2025, Ted Rosen, MD, and Vikash Oza, MD, discuss emerging infectious diseases in dermatology, highlighting new treatments and diagnostic challenges for clinicians.

Catch up on coverage from the second day of the Maui Derm NP+PA Fall 2025 conference held in Nashville, Tennessee.

Discover expert insights on cutaneous oncology from George Martin, MD, focusing on innovative treatments for skin cancers at Maui Derm NP+PA Fall.

Discover key insights from the Maui Derm NP+PA Fall 2025 Conference on advances in dermatology, including new treatments and research findings.

Discover groundbreaking dermatologic therapies and new drug approvals presented at Maui Derm NP+PA Fall, featuring insights from experts George Martin, MD, and Ted Rosen, MD.

Catch up on coverage from the first day of the Maui Derm NP+PA Fall 2025 conference held in Nashville, Tennessee.

Elena Hawryluk, MD, PhD, highlights innovative pediatric dermatology at Maui Derm NP+PA Fall, emphasizing education and advancements in tumor genetics.

Preview the Maui Derm NP+PA Fall 2025 Conference with program director George Martin, MD, featuring cutting-edge education and expert insights in Nashville.

Preview Maui Derm NP+PA Fall 2025 Conference's 4 days of cutting-edge dermatology insights, networking, and expert-led sessions in Nashville.

In the latest Cutaneous Connection podcast episode, Renata Block, DMSc, MMS, PA-C, and Isabelle Thibau, MPH, discuss the National Eczema Association's EczemaWise app and how it can be used by both clinicians and patients.

Renata Block, DMSc, MMS, PA-C, and Isabelle Thibau, MPH, of the National Eczema Association discuss how the EczemaWise app integrates patient-reported outcomes, validated tools, and real-world data to improve collaboration between patients and clinicians in managing eczema.

GLP-1 receptor agonists may indirectly affect dermatologic outcomes by targeting inflammation and metabolic comorbidities.

Members of Elevate-Derm Alliance and the SkinSync podcast discuss the inspiration behind the podcast and how it best serves dermatology clinicians.

Andrew Baker, MBA, MPAS, PA-C, discusses new data highlighting both the growing challenges—like burnout and reimbursement cuts—and exciting opportunities in leadership, virtual care, and mentorship for PAs and NPs.

Discover how biologic coordinators streamline dermatologic care through detailed protocols, clinical documentation, and patient advocacy to improve access to life-changing biologic therapies.

Strong mentorship provides resilience for young clinicians navigating evolving challenges in practice.

Renata Block, DMSc, MMS, PA-C, interviews Adam Friedman, MD, FAAD, about his research into cannabidiol’s photoprotective potential, clinical trial design, and future directions.

Explore career transitions in healthcare as PAs Renata Block, DMS-c, MMS, PA-C, and Jessica Dell'Aquila, MS, PA-C, share insights on professional growth and evolving roles in dermatology.

At Elevate-Derm Summer, Shanna Miranti, MPAS, PA-C, highlighted practical strategies for isotretinoin prescribing, addressed the impact of iPLEDGE hurdles, and introduced the SkinSync podcast.

Jacki Kment, PA-C, MPAS, DFAAPA, shares how she built a successful direct pay dermatology practice to prioritize patient care and professional balance.

With longer visits and flat-rate pricing, Kment’s practice provides personalized dermatologic care to both insured and uninsured patients.

Renata Block, DMSc, MMS, PA-C, interviews Amy Snow, PA-C, who shares how she transformed career roadblocks into a mobile dermatology clinic delivering free care and hope across Oregon.

Although bimekizumab carries a precaution for suicidal ideation and behavior, current data suggest it may improve mental health outcomes for patients with psoriasis.

Renata Block, DMSc, MMS, PA-C, interviews Andrew Baker, PA-C, MBA, to discuss his role as a sub-investigator in Castle Biosciences’ UTILISE study for cSCC.